Abstract: An apparatus for predicting performance of a wheel in a vehicle: includes a learning device that generates a latent space for a plurality of two-dimensional (2D) wheel images based on a convolutional autoencoder (CAE), extracts a predetermined number of the plurality of 2D wheel images from the latent space, and learns a dataset having the plurality of 2D wheel images and performance values corresponding to the plurality of 2D wheel images; and a controller that predicts performance for the plurality of 2D wheel images based on a performance prediction model obtained by the learning device.

Abstract: A method and apparatus for measuring optical characteristics of an augmented reality device are disclosed. A method of measuring optical characteristics of an augmented reality device according to an exemplary embodiment of the present invention includes: taking a test image including a plurality of patterns that is output on a virtual plane by the augmented reality device, using at least one camera disposed around a predetermined measurement reference position; acquiring field of view information including information about the field of view of the at least one camera, and photographing system information including information about the arrangement of the at least one camera; and calculating the coordinates of a plurality of patterns with respect to the measurement reference position on the basis of a plurality of captured images taken by the at least one camera, field of view information, and photographing system information.

Abstract: An apparatus and method for monitoring a driver with epilepsy using a brain wave signal are disclosed. The monitoring method includes collecting a brain wave signal for a driver with epilepsy in a mobility for a predetermined time, determining the driver's state by analyzing the brain wave signal collected for the predetermined time, and controlling an operation of the mobility on the basis of the determined driver's state.

Abstract: There is provided a mutation complex including: a BMPR2-E376K mutant in which an amino acid at position 376 of BMPR2 gene encoding a bone morphogenetic protein type 2 receptor (BMPR2) has mutated from glutamic acid (E) to lysine (K); and an ACVR1-R206H mutant in which an amino acid at position 206 of ACVR1 gene encoding an activin A type I receptor (ACVR1) has mutated from arginine (R) to histidine (H). There are also provided induced pluripotent stem cells reprogrammed from cells including the BMPR2-E376K mutant in which an amino acid at position 376 of BMPR2 gene encoding a bone morphogenetic protein type 2 receptor (BMPR2) has mutated from glutamic acid (E) to lysine (K).

Abstract: Disclosed is a technique for identifying a mutation of a particular gene as a new case of a FOP-like phenotype, in addition to the existing ACVR1-R206H mutation known as a cause of FOP and utilizing the identified mutation in the bone disease treatment through osteogenic differentiation. There is provided a bone morphogenetic protein type 2 receptor (BMPR2)-E376K mutant in which the 376th amino acid glutamic acid (E) is mutated into lysine (K) in the BMPR2 gene encoding BMPR2.

Abstract: An apparatus for providing a customized mobility driving path using a brain wave signal includes a sensor configured to collect a brain wave signal for a driver of a mobility in a predetermined channel region, an analyzer configured to determine information to be provided regarding a planned path by analyzing the brain wave signal collected in the predetermined channel region, and a controller configured to control an operation of the mobility based on the information to be provided.

Abstract: A display device includes a display panel; a chassis disposed at a rear side of the display panel; a control circuit board disposed on the chassis; a shield case disposed on the control circuit board; and a fan disposed on the chassis and adjacent to the shield case. The shield case includes a main portion spaced apart from the control circuit board in a third direction, and side portions extending toward the chassis from opposite sides of the main portion. Dimples are formed in an inner surface of the main portion facing toward the control circuit board.

Abstract: An error monitoring apparatus and method are provided. The error monitoring method includes collecting an Event-Related Potential (ERP) for at least one passenger in a first mobility for a predetermined amount of time, analyzing the ERP collected for the predetermined amount of time, and transmitting error information of the first mobility to a traffic control server based on a result of analysis. The error information of the first mobility includes at least one of information on a time when the ERP is generated, a waveform of the ERP, position information of the first mobility or operation information of a second mobility, and the second mobility is different from the first mobility and has caused the ERP.

Abstract: An apparatus for determining ride comfort of a passenger using brain wave signals includes an analyzer configured to determine first ride comfort information of a passenger based on information on a seating posture of the passenger in a mobility, a sensor configured to collect brain wave signals of the passenger in the mobility for a predetermined time, and a controller configured to control the mobility, wherein the analyzer is configured to determine second ride comfort information obtained by correcting the first ride comfort information, by analyzing the collected brain wave signals based on the first ride comfort information, and wherein the controller is configured to control the mobility based on the determined second ride comfort information.

Abstract: An apparatus for generating an image using brain wave signals includes a sensor configured to collect brain wave signals of at least one passenger in a mobility from a plurality of channels for a predetermined time, and a controller configured to generate a first image from the brain wave signals collected from the plurality of channels using an artificial intelligence model, to select at least one second image included in a predetermined list based on the generated first image, and to control the mobility as a response to the selected second image.

Abstract: Provided is a medical implant including: an implant base having a surface made of a silicon material; a linker having one end attached onto the surface of the implant base; and a cytokine bound to another end of the linker. By inducing the secretion of anti-inflammatory cytokines, a capsular contracture, which is one of the complications that may occur after transplantation of the patient's breast implant, may occur less.

Abstract: An error monitoring apparatus and method are provided. The error monitoring method includes determining whether or not a predetermined event has occurred to a first mobility; sensing to collect an event-related potential (ERP) for at least one passenger of the first mobility for a predetermined amount of time, analyzing the collected ERP based on the determination, and transmitting error information of the first mobility to a traffic control server based on an analysis result. Herein, the predetermined event includes a traffic accident related at least to the first mobility, and the error information of the first mobility includes at least one of time information regarding when the ERP occurs, a waveform of the ERP, location information of the first mobility, or operational information of the first mobility.

Abstract: A novel organic sulfur compound, a method for preparing the same, and a pharmaceutical composition for preventing or treating cancer or inflammatory diseases, containing the same as an active ingredient are provided. The novel organic sulfur compound is capable of excellently inhibiting histone deacetylated (HDAC) enzymes in a concentration of nanomolar or micromolar units and has been found to have an excellent effect against inflammatory diseases, and has been found to be capable of inhibiting the proliferation of cancer.

Abstract: A novel organic sulfur compound, a method for preparing the same, and a pharmaceutical composition for preventing or treating cancer or inflammatory diseases, containing the same as an active ingredient are provided. The novel organic sulfur compound is capable of excellently inhibiting histone deacetylated (HDAC) enzymes in a concentration of nanomolar or micromolar units and has been found to have an excellent effect against inflammatory diseases, and has been found to be capable of inhibiting the proliferation of cancer.

Abstract: An apparatus and method for monitoring a driver with epilepsy using a brain wave signal are disclosed. The monitoring method includes collecting a brain wave signal for a driver with epilepsy in a mobility for a predetermined time, determining the driver's state by analyzing the brain wave signal collected for the predetermined time, and controlling an operation of the mobility on the basis of the determined driver's state.

Abstract: An apparatus and a method for selecting an item using a brain wave signal are disclosed. The method for selecting an item includes: receiving, by a receiver, information on at least one item from a service point; displaying, by a display, the received information on a predetermined area in a mobility; in response to the displayed information, collecting, by a sensor, a brain wave signal for at least one passenger in the mobility for a predetermined time; and determining, by a controller, the passenger's choice by analyzing the collected brain wave signal.

Abstract: An error monitoring apparatus and method are provided. The error monitoring method includes determining whether or not a predetermined event has occurred to a first mobility; sensing to collect an event-related potential (ERP) for at least one passenger of the first mobility for a predetermined amount of time, analyzing the collected ERP based on the determination, and transmitting error information of the first mobility to a traffic control server based on an analysis result. Herein, the predetermined event includes a traffic accident related at least to the first mobility, and the error information of the first mobility includes at least one of time information regarding when the ERP occurs, a waveform of the ERP, location information of the first mobility, or operational information of the first mobility.

Abstract: An error monitoring apparatus and method are provided. The error monitoring method includes collecting an Event-Related Potential (ERP) for at least one passenger in a first mobility for a predetermined amount of time, analyzing the ERP collected for the predetermined amount of time, and transmitting error information of the first mobility to a traffic control server based on a result of analysis. The error information of the first mobility includes at least one of information on a time when the ERP is generated, a waveform of the ERP, position information of the first mobility or operation information of a second mobility, and the second mobility is different from the first mobility and has caused the ERP.

Abstract: A mobility controlling method and apparatus based on error monitoring are provided. The mobility controlling method includes: collecting an Event-Related Potential (ERP) for at least one passenger in a mobility for a predetermined time, determining an error factor by analyzing the ERP that is collected for the predetermined time, and performing mobility feedback based on the error factor.

Abstract: A method of inhibiting the growth of cancer stem cells, including administering an effective amount of a protein kinase D1 expression or activity inhibitor as an active ingredient to a subject having cancer is provided. Further, a method of treating cancer, including administering an effective amount of a protein kinase D1 expression or activity inhibitor, and antitumor agent as active ingredients to a subject having cancer is provided. Further, a method for measuring expression or activity of protein kinase D1 for providing information of breast cancer prognosis, including a step of measuring expression or activity of protein kinase D1 in cells or tissues isolated from a subject is provided.